Equity.Guru podcast: ProMis Neurosciences (PMN.T) and the fight against Alzheimer’s

Someone in the world develops dementia every 3 seconds.

Alzheimer's disease and other dementia-related disorders affect 50M people around the world and that number is expected to double to 131.5M by 2050, that is, unless companies like ProMis Neurosciences (PMN.T) can do the unthinkable.

Equity.Guru's own Ethan Reyes takes a quick look at the company and the challenges of the sector. Will biotech provide a safe option to investors while the cannabis market continues to correct?

Listen in!